Overview

Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 Diabetes

Status:
Completed
Trial end date:
2018-08-16
Target enrollment:
Participant gender:
Summary
In the proposed study, hydroalcoholic Fenugreek seed extract will used add-on to the existing therapy in patients with type-2 diabetes. The efficacy and safety of the extract will be evaluated using standard methodology.
Phase:
N/A
Details
Lead Sponsor:
All India Institute of Medical Sciences, Bhubaneswar
Collaborator:
Chemical Resources
Treatments:
Fenugreek seed meal
Hypoglycemic Agents
Metformin